HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$0.69
Day range
$0.66 - $0.70
Year range
$0.20 - $2.54
Market cap
80.11M USD
Avg Volume
1.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 27.36M | 2,131.40% |
Operating expense | 9.76M | -29.44% |
Net income | -31.75M | 57.53% |
Net profit margin | -116.07 | 98.10% |
Earnings per share | -0.23 | 68.06% |
EBITDA | -25.10M | 65.96% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 46.24M | -77.49% |
Total assets | 165.27M | -45.29% |
Total liabilities | 263.58M | 11.16% |
Total equity | -98.31M | — |
Shares outstanding | 120.42M | — |
Price to book | -0.85 | — |
Return on assets | -40.05% | — |
Return on capital | 163.91% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -31.75M | 57.53% |
Cash from operations | -29.61M | 22.94% |
Cash from investing | 14.72M | 345.00% |
Cash from financing | 24.14M | 10,172.77% |
Net change in cash | 9.25M | 120.92% |
Free cash flow | 18.94M | 262.74% |
About
Founded
2012
Headquarters
Website
Employees
173